CRYSTAL WILLIAMS: Open Payments
NPI 1477026045 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $84 |
| Neurocrine BioSciences, Inc. | 2 | $62 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Neos Therapeutics, LP | 1 | $20 |
Products named: ARISTADA, INGREZZA, TRINTELLIX, Sunosi, Auvelity, Adzenys XR-ODT.
Industry payments across MD — which companies pay providers there.
